• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Cytokine immunotrapping: an assay to study the kinetics of production and consumption or degradation of human interferon-gamma.

作者信息

Akdiş A C, Towbin H, Libsig P, Motz J, Alkan S S

机构信息

Department of Asthma/Allergy, Ciba-Geigy Ltd., Basel, Switzerland.

出版信息

J Immunol Methods. 1995 Jun 9;182(2):251-61. doi: 10.1016/0022-1759(95)00055-f.

DOI:10.1016/0022-1759(95)00055-f
PMID:7790729
Abstract

With the aim of determining the rate of cytokine production, we have investigated immunoassay conditions which prevent consumption/degradation. These assays, termed cytokine immunotrapping assays (CITA), are based on early capturing of cytokines secreted during cell culture by immobilised or soluble mAbs and a recently described chemiluminescent immunoassay. Here we describe assay conditions using IFN-gamma as a prototype cytokine. For production of IFN-gamma, PBMC, purified CD4+ or CD8+ T cells, or diluted whole blood were cultured with different T cell stimulating agents. Polystyrene macrobeads precoated with an anti-IFN-gamma mAb were put in culture and after a defined incubation period, a dimethyl acridinium ester (DMAE)-labelled second anti-IFN-gamma mAb and sodium azide were added into the culture for additional 24 h. The beads were washed and chemiluminescence signals determined in a luminometer. Trapping experiments were also performed with the beads or the soluble mAbs alone. Irrespective of the configuration, IFN-gamma concentrations measured in trapping conditions were always higher (3-20-fold) than in conventional cultures. By using the best trapping combination, i.e. both bead-mAb1 and DMAE-mAb2 added at the start of culture (single step), it was possible to detect IFN-gamma production as early as 2 h. Also, IFN-gamma secreted by less than 500 PBMC or whole blood cells could be detected within 24 h. When purified CD4+ or CD8+ cells were used instead of PBMC, a reduction of the trapping effect was observed. Conversely, addition of monocytes to purified T cells increased the trapping factor suggesting that a substantial amount of IFN-gamma was consumed or degraded both by CD14+ cells as well as T cells in culture. Preliminary results show that this assay is also suitable for the early detection of IL-1 and IL-4 which are known to be more tightly regulated. Thus, the new principle described here is expected to be useful in clinical settings where both the time and amounts of material are limited to investigate the role of cytokines in particular disease.

摘要

相似文献

1
Cytokine immunotrapping: an assay to study the kinetics of production and consumption or degradation of human interferon-gamma.
J Immunol Methods. 1995 Jun 9;182(2):251-61. doi: 10.1016/0022-1759(95)00055-f.
2
IL-2 receptor blockade inhibits late, but not early, IFN-gamma and CD40 ligand expression in human T cells: disruption of both IL-12-dependent and -independent pathways of IFN-gamma production.白细胞介素-2受体阻断抑制人T细胞中晚期而非早期的γ干扰素和CD40配体表达:破坏γ干扰素产生的白细胞介素-12依赖性和非依赖性途径。
J Immunol. 2002 Sep 1;169(5):2736-46. doi: 10.4049/jimmunol.169.5.2736.
3
Activated T lymphocytes regulate hyaluronan binding to monocyte CD44 via production of IL-2 and IFN-gamma.活化的T淋巴细胞通过产生白细胞介素-2和γ-干扰素来调节透明质酸与单核细胞CD44的结合。
J Immunol. 2001 Jan 1;166(1):188-96. doi: 10.4049/jimmunol.166.1.188.
4
Chemiluminescent and enzyme-linked immuno assays for sensitive detection of human IFN-gamma.用于灵敏检测人γ干扰素的化学发光和酶联免疫分析
J Immunoassay. 1994 Aug;15(3):217-38. doi: 10.1080/15321819408009574.
5
Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells.干扰素α可增加产生干扰素γ的人CD4+T细胞的频率。
J Exp Med. 1993 Nov 1;178(5):1655-63. doi: 10.1084/jem.178.5.1655.
6
Decreased frequency of interferon-gamma- and interleukin-2-producing cells in patients with atopic diseases measured at the single cell level.在单细胞水平上检测到特应性疾病患者中产生干扰素-γ和白细胞介素-2的细胞频率降低。
J Allergy Clin Immunol. 1995 Oct;96(4):515-27. doi: 10.1016/s0091-6749(95)70296-2.
7
Optimization of a bovine cytokine multiplex assay using a new bovine and cross-reactive equine monoclonal antibodies.优化一种新的牛和交叉反应性马的单克隆抗体的牛细胞因子多重分析检测方法。
Vet Immunol Immunopathol. 2024 Jul;273:110789. doi: 10.1016/j.vetimm.2024.110789. Epub 2024 May 23.
8
Aberrant cytokine production by Sezary syndrome patients: cytokine secretion pattern resembles murine Th2 cells.蕈样肉芽肿患者异常的细胞因子产生:细胞因子分泌模式类似于小鼠Th2细胞。
J Invest Dermatol. 1992 Jul;99(1):90-4. doi: 10.1111/1523-1747.ep12611877.
9
Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production.干扰素-γ诱导因子增强人T细胞受刺激后产生的辅助性T细胞1细胞因子:与白细胞介素-12协同促进干扰素-γ的产生。
Eur J Immunol. 1996 Jul;26(7):1647-51. doi: 10.1002/eji.1830260736.
10
Dominant role for TL1A/DR3 pathway in IL-12 plus IL-18-induced IFN-gamma production by peripheral blood and mucosal CCR9+ T lymphocytes.TL1A/DR3通路在白细胞介素-12加白细胞介素-18诱导外周血和黏膜CCR9 + T淋巴细胞产生干扰素-γ过程中起主导作用。
J Immunol. 2005 Apr 15;174(8):4985-90. doi: 10.4049/jimmunol.174.8.4985.

引用本文的文献

1
CCR6 Th cells in the cerebrospinal fluid of persons with multiple sclerosis are dominated by pathogenic non-classic Th1 cells and GM-CSF-only-secreting Th cells.多发性硬化症患者脑脊液中的CCR6辅助性T细胞以致病性非经典辅助性T1细胞和仅分泌粒细胞-巨噬细胞集落刺激因子的辅助性T细胞为主。
Brain Behav Immun. 2017 Aug;64:71-79. doi: 10.1016/j.bbi.2017.03.008. Epub 2017 Mar 20.
2
Exploring the feasibility of selective depletion of T lymphocyte subsets by whole blood immunoadsorption cytapheresis.探讨全血免疫吸附血细胞分离术选择性清除T淋巴细胞亚群的可行性。
Clin Exp Immunol. 2007 Dec;150(3):477-86. doi: 10.1111/j.1365-2249.2007.03518.x. Epub 2007 Oct 9.
3
Back to the future: antibody-based strategies for the treatment of infectious diseases.
回到未来:基于抗体的传染病治疗策略。
Mol Biotechnol. 2002 Jul;21(3):225-39. doi: 10.1385/MB:21:3:225.